ChEMBL

Medeloop Achieves Milestone with One Million Patient Health Records, Pioneering Advances in Clinical and Translational Research

Retrieved on: 
Monday, April 8, 2024
UCSD, Health informatics, ChEMBL, Patient, Research, Health, PubMed, PubChem, Pharmaceutical industry

This significant achievement underscores the company's dedication to revolutionizing the field of clinical research and confirms the industry's trust in its advanced data analytics capabilities to improve patient care.

Key Points: 
  • This significant achievement underscores the company's dedication to revolutionizing the field of clinical research and confirms the industry's trust in its advanced data analytics capabilities to improve patient care.
  • With this milestone, Medeloop is reaffirming its commitment to leveraging innovative, data-driven solutions to transform patient care and enhance health outcomes on a global scale.
  • This advancement will enable researchers to perform comprehensive analyses, identify trends, and extract vital insights, significantly accelerating the pace of meaningful breakthroughs in healthcare.
  • "We are thrilled to collaborate with Dr. Mike Hogarth to unlock the potential of healthcare data," said CEO Rene Caissie at Medeloop.

Exscientia Announces Expansion of its Technology Leadership Team

Retrieved on: 
Thursday, June 29, 2023
Health, Pharmaceutical, Technology, Health Technology, Artificial Intelligence, University College London, Medicines Discovery Catapult, Society, SAGE, University, Doctor of Philosophy, ChEMBL, Engineering, Head, Wellcome Trust, COVID-19, Chartered Institute of Architectural Technologists, Engineering and Physical Sciences Research Council, European Bioinformatics Institute, Woman, Medicine, UK Research and Innovation, Female, Drug design, Structural bioinformatics, Committee, Computer Weekly, Publication, Patient, Machine learning, Clinical Medicine & Research, UKRI, EBI, Physics, Drug discovery, Emergency, Artificial intelligence, STEM, AI, Research, Outline of physical science, Pfizer, Pharmaceutical industry, Management, Biochemistry, Chemistry

In addition, use of the company’s technology has grown far beyond medicinal chemistry, including personalised medicine, target identification and laboratory automation.

Key Points: 
  • In addition, use of the company’s technology has grown far beyond medicinal chemistry, including personalised medicine, target identification and laboratory automation.
  • The company’s change in management structure announced today will further align executive decision making with its functional priorities in technology.
  • “Under Garry's leadership, Exscientia has built a scalable technology stack, established automation laboratories and grown its technology team to over 200 employees,” said Professor Andrew Hopkins FRS FMedSci, founder and Chief Executive Officer of Exscientia.
  • She joined Exscientia as Chief Information Officer in May 2022 from Wellcome Trust, where she formed part of the senior leadership and led digital transformation as Head of Technology.